Literature DB >> 10980896

Management of heart failure.

T H Le Jemtel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10980896     DOI： 10.1007/s11886-000-0072-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  17 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.

Authors:  O H Frazier; R J March; K A Horvath
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

3.  Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

Authors:  M Packer; P A Poole-Wilson; P W Armstrong; J G Cleland; J D Horowitz; B M Massie; L Rydén; K Thygesen; B F Uretsky
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

4.  The influence of left ventricular filling pressure on atrial contribution to cardiac output.

Authors:  B Greenberg; K Chatterjee; W W Parmley; J A Werner; A N Holly
Journal:  Am Heart J       Date:  1979-12       Impact factor: 4.749

5.  Transmyocardial laser revascularization: early results and 1-year follow-up.

Authors:  R Agarwal; M Ajit; V M Kurian; S Rajan; S B Arumugam; K M Cherian
Journal:  Ann Thorac Surg       Date:  1999-02       Impact factor: 4.330

6.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

7.  Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure.

Authors:  D M Mancini; L Davis; J P Wexler; B Chadwick; T H LeJemtel
Journal:  J Am Coll Cardiol       Date:  1987-10       Impact factor: 24.094

8.  Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.

Authors:  D L Dries; D V Exner; B J Gersh; M J Domanski; M A Waclawiw; L W Stevenson
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

9.  Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm.

Authors:  M Pozzoli; G Cioffi; E Traversi; G D Pinna; F Cobelli; L Tavazzi
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

10.  Transmyocardial laser revascularization: clinical experience with twelve-month follow-up.

Authors:  D A Cooley; O H Frazier; K A Kadipasaoglu; M H Lindenmeir; S Pehlivanoglu; J W Kolff; S Wilansky; W H Moore
Journal:  J Thorac Cardiovasc Surg       Date:  1996-04       Impact factor: 5.209
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.